Press release
31.07.2013 NAMMD press release Press Release of the National Agency for Medicines and Medical Devices on recall of batches T737E […]
Important notification
31.07.2013 NAMMD press release Press release of the National Agency for Medicines and Medical Devices on withdrawal from the market […]
Important notification
25.07.2013 To the attention of Marketing Authorisation Holders The following are applied as of 5 August 2013 concerning applications for […]
Important notification
11.06.2013 To the attention of interested persons Invoices are to be submitted within 5 working days by email (or by […]
Press release
10.06.2013 To the attention of healthcare professionals NAMMD press release on market withdrawal, at wholesale distributor level, of CILEST 0.250mg/0.035mg, […]
Important notification
05.06.2013 To the attention of interested persons NAMMD press release on market withdrawal, at wholesale distributor level, of CILEST 0.250mg/0.035mg, […]
Important notification
05.06.2013 To the attention of interested persons The NAMMD, in cooperation with ARPIM and APMGR announce the “Quality of the […]
Important notification
05.06.2013 To the attention of interested persons Press release of the National Agency for Medicines and Medical Devices on the […]
Important notification
07.05.2013 To the attention of Marketing Authorisation Holders As regards medicinal products submitted for marketing authorisation renewal through national procedure, […]
Important notification
05.03.2013 To the attention of Marketing Authorisation Holders Submission of the pharmacovigilance system summary for medicinal products undergoing marketing authorisation […]